Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Sajid Javid lauds community pharmacy for doing an ‘amazing job’ over the entire pandemic

Health secretary Sajid Javid has acknowledged and appreciated the hard work done by community pharmacies in serving people during the Covid-19 pandemic.

“Community pharmacies have done an absolutely amazing job over the entire pandemic right from day one,” he said, on the sidelines of a roundtable held at the Department of Health and Social Care in central London on September 28.


“They were on the frontline, they stayed open when many other businesses, we understand, had to be closed, because they're more than a business. They are part of your community serving critical needs.”

He added that during the pandemic, community pharmacies stepped up to deliver more than their routine services, by providing additional care in several ways and advising the country that was in a state of shock at the start of the crisis.

Javid said: “We didn't have the answer. So first of all, I can't thank community pharmacists enough for what they've been doing throughout the pandemic – when it comes to helping with vaccination programme, or in other ways.

“We absolutely need to make sure that they're getting the support that they need. We constantly keep it under review.”

Meetings with sector leaders

Health secretary Javid informed that he often meets with community pharmacy leaders to discuss their needs.

“I think that dialogue is important to make sure that we're listening and doing everything.”

Talking about the success of Covid vaccination drive in the country, he said: “Britain has been a leader in vaccine uptake. But it's been uneven.”

The national vaccination data shows the uptake of more than 80 per cent for a double dose, but a community-based segregation shows a different picture.

Vaccine uptake

Vaccination uptake amongst the British Indian community stands at 70 per cent, and for the British Pakistani community, it's about 55 per cent.

Javid said: “It has improved a lot in the last couple of months. But I wanted to certainly encourage more people to take up the offered vaccine, if you're eligible. Please take it because we know it saves lives when it protects those people around you, and not just those who are taking the vaccine.”

He added that all medical organisations including the British Medical Association agree on this that “the vaccine works.”

“There are 200,000 or fewer people in hospital because of the vaccines, there are 126,000 fewer deaths because of the vaccines and that really has got to be a central message.

To be able to say goodbye to this pandemic at some point in the future “we just need more people to take up the vaccine if it is offered to them.”

More For You

Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less
NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less